The effect of neoadjuvant radiation therapy on perioperative outcomes among patients undergoing resection of retroperitoneal sarcomas

Neoadjuvant radiation therapy (RT) has several theoretical benefits in the treatment of retroperitoneal sarcoma (RPS), but concerns remain about treatment toxicity and perioperative morbidity. There are limited data regarding its effect on perioperative outcomes, most of which come from small, single-institution series. The purpose of this study was to evaluate the short-term (30-day) postoperative morbidity and mortality associated with neoadjuvant RT following resection of RPS.

Source: Surgical Oncology - July 23, 2014 Category: Surgery Authors: Daniel P. Nussbaum, Paul J. Speicher, Brian C. Gulack, Asvin M. Ganapathi, Jeffrey E. Keenan, Sandra S. Stinnett, David G. Kirsch, Douglas S. Tyler, Dan G. Blazer Tags: Review Source Type: research